candesartan has been researched along with Invasiveness, Neoplasm in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suganuma, T | 1 |
| Ino, K | 1 |
| Shibata, K | 1 |
| Kajiyama, H | 1 |
| Nagasaka, T | 1 |
| Mizutani, S | 1 |
| Kikkawa, F | 1 |
| Cazaubon, S | 1 |
| Deshayes, F | 1 |
| Couraud, PO | 1 |
| Nahmias, C | 1 |
1 review available for candesartan and Invasiveness, Neoplasm
| Article | Year |
|---|---|
[Endothelin-1, angiotensin II and cancer].
Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Age | 2006 |
1 other study available for candesartan and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD34; Be | 2005 |